Apart from ACTB, PPIA, RPL13A, RPLP0, and TBP, HRPT1 (P = 0.57) and PBGD (P = 0.70) demonstrated relatively equivalent expression in the 13 mucinous ovarian tumors (benign tissues, n = 7; borderline tissues, n = 3; malignant tissues, n = 3, Fig. 2C); whereas, the expression of B2M (P = 0.29) was not significantly different in the 19 serous neoplasms (benign, n = 3; borderline, n = 4; malignant, n = 12, Fig. 2D). This evidence concerns the gene HMBS and ovarian mucinous neoplasm.